Cracking “Undruggable” Cancer Proteins: Precision Oncology Meets p53
The development of KRAS inhibitors has ushered in a new era in precision oncology and renewed efforts in therapeutic...
Author:
Silvia Licciulli, PhD
The development of KRAS inhibitors has ushered in a new era in precision oncology and renewed efforts in therapeutic...
The recent AACR Grantee Summit showcased the impactful research funded by AACR grants, including new targeted therapy approaches, miniaturized...
At the recent AACR Conference on Pancreatic Cancer, researchers explored the complex interactions among tumor cells, neurons, and the...
At the recent AACR Conference on Pancreatic Cancer, Kevan M. Shokat, PhD, FAACR, received the 2026 Stephenson Global Prize...
Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use...
In contrast with many cancers, uterine cancer incidence and mortality are on the rise. The disease, which is a...
The AACR Project GENIE Data Model, recently released by the AACR GENIE consortium, is an open-access tool designed to...
Cancer immunology expert and former AACR president Elizabeth Jaffee, MD, FAACR, discusses the latest progress in the research on...
At the AACR Annual Meeting 2026, a session highlighted progress from four Cancer Grand Challenges teams on the interplay...
At the AACR Annual Meeting 2026, researchers discussed the use of vaccines and aspirin to prevent cancer in people...